News Room

1 - 10 of 1182

Two CHOP Patients with an Inherited Blindness Successfully Treated with Gene Editing

Published on

A multi-institutional clinical trial involving researchers from Children’s Hospital of Philadelphia (CHOP) and the Scheie Eye Institute at the University of Pennsylvania found that CRISPR-Cas9 gene editing delivered to fourteen individuals with a form of inherited blindness was safe and led to measurable improvements in vision in nearly half of the of the participants treated, including the two children treated at CHOP. The findings were published today in the New England Journal of Medicine.

News Archive Search

Can't find what you are looking for? Search the news archives.